Index by author

01 February 2002; volume 19, issue 2

A

  1. Abramson, M.

    1. Ward, R.J. et al "European Community Respiratory Health Survey calibration project of dosimeter driving pressures." European Respiratory Journal 19.2 (2002): 252-256. Web. 16 Feb. 2020.

  2. Alegre, J.

    1. Alegre, J. et al "Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions." European Respiratory Journal 19.2 (2002): 320-325. Web. 16 Feb. 2020.

  3. Aleman, C.

    1. Alegre, J. et al "Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions." European Respiratory Journal 19.2 (2002): 320-325. Web. 16 Feb. 2020.

  4. Angrill, J.

    1. Ioanas, M. et al "Bronchial bacterial colonization in patients with resectable lung carcinoma." European Respiratory Journal 19.2 (2002): 326-332. Web. 16 Feb. 2020.

  5. App, E.M.

    1. App, E.M. et al "Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis." European Respiratory Journal 19.2 (2002): 294-302. Web. 16 Feb. 2020.

  6. Arancibia, F.

    1. Ioanas, M. et al "Bronchial bacterial colonization in patients with resectable lung carcinoma." European Respiratory Journal 19.2 (2002): 326-332. Web. 16 Feb. 2020.

  7. Armadans, L.

    1. Alegre, J. et al "Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions." European Respiratory Journal 19.2 (2002): 320-325. Web. 16 Feb. 2020.

  8. Arsac, P.

    1. Raherison, C. et al "Management of lower respiratory tract infections by French general practitioners: the AIR II study." European Respiratory Journal 19.2 (2002): 314-319. Web. 16 Feb. 2020.

B

  1. Baldo, X.

    1. Ioanas, M. et al "Bronchial bacterial colonization in patients with resectable lung carcinoma." European Respiratory Journal 19.2 (2002): 326-332. Web. 16 Feb. 2020.

  2. Balmes, J.

    1. Shusterman, D. et al "Chlorine exposure and the upper respiratory tract." European Respiratory Journal 19.2 (2002): 381-383. Web. 16 Feb. 2020.

  3. Bantje, Th.A.

    1. Vincken, W. et al "Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium." European Respiratory Journal 19.2 (2002): 209-216. Web. 16 Feb. 2020.

  4. Baran, D.

    1. App, E.M. et al "Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis." European Respiratory Journal 19.2 (2002): 294-302. Web. 16 Feb. 2020.

  5. Bauer, T.

    1. Ioanas, M. et al "Bronchial bacterial colonization in patients with resectable lung carcinoma." European Respiratory Journal 19.2 (2002): 326-332. Web. 16 Feb. 2020.

  6. Baur, X.

    1. Merget, R. et al "Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate." European Respiratory Journal 19.2 (2002): 377-380. Web. 16 Feb. 2020.

  7. Beamis, J.F.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  8. Becker, H.D.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  9. Bijl-Hofland, I.D.

    1. van Schayck, C.P. et al "Potential masking effect on dyspnoea perception by short- and long-acting β2-agonists in asthma." European Respiratory Journal 19.2 (2002): 240-245. Web. 16 Feb. 2020.

  10. Blanc, P.

    1. Shusterman, D. et al "Chlorine exposure and the upper respiratory tract." European Respiratory Journal 19.2 (2002): 381-383. Web. 16 Feb. 2020.

  11. Bogle, S.

    1. Whitehead, A. et al "Once-daily tobramycin in the treatment of adult patients with cystic fibrosis." European Respiratory Journal 19.2 (2002): 303-309. Web. 16 Feb. 2020.

  12. Bonsignore, G.

    1. Melis, M. et al "Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects." European Respiratory Journal 19.2 (2002): 257-266. Web. 16 Feb. 2020.

  13. Brade, H.

    1. Gaede, K.I. et al "Anti-Chlamydophila immunoglobulin prevalence in sarcoidosis and usual interstitial pneumoniae." European Respiratory Journal 19.2 (2002): 267-274. Web. 16 Feb. 2020.

  14. Brade, L.

    1. Gaede, K.I. et al "Anti-Chlamydophila immunoglobulin prevalence in sarcoidosis and usual interstitial pneumoniae." European Respiratory Journal 19.2 (2002): 267-274. Web. 16 Feb. 2020.

  15. Brown, V.

    1. Warke, T.J. et al "Outgrown asthma does not mean no airways inflammation." European Respiratory Journal 19.2 (2002): 284-287. Web. 16 Feb. 2020.

C

  1. Caldwell, N.A.

    1. Whitehead, A. et al "Once-daily tobramycin in the treatment of adult patients with cystic fibrosis." European Respiratory Journal 19.2 (2002): 303-309. Web. 16 Feb. 2020.

  2. Canalis, E.

    1. Ioanas, M. et al "Bronchial bacterial colonization in patients with resectable lung carcinoma." European Respiratory Journal 19.2 (2002): 326-332. Web. 16 Feb. 2020.

  3. Casaburi, R.

    1. Casaburi, R. et al "A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease." European Respiratory Journal 19.2 (2002): 217-224. Web. 16 Feb. 2020.

  4. Cavaliere, S.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  5. Chen, Y.Z.

    1. Wong, G.W.K. et al "Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children." European Respiratory Journal 19.2 (2002): 288-293. Web. 16 Feb. 2020.

  6. Chen, Z.

    1. Merget, R. et al "Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate." European Respiratory Journal 19.2 (2002): 377-380. Web. 16 Feb. 2020.

  7. Clanton, T.L.

    1. Clanton, T.L.. "A breakthrough in the functional evaluation of the inspiratory muscle pump." European Respiratory Journal 19.2 (2002): 207-208. Web. 16 Feb. 2020.

  8. Cloosterman, S.G.M.

    1. van Schayck, C.P. et al "Potential masking effect on dyspnoea perception by short- and long-acting β2-agonists in asthma." European Respiratory Journal 19.2 (2002): 240-245. Web. 16 Feb. 2020.

  9. Coffiner, M.

    1. App, E.M. et al "Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis." European Respiratory Journal 19.2 (2002): 294-302. Web. 16 Feb. 2020.

  10. Colby, T.V.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  11. Colt, H.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  12. Conway, S.P.

    1. Whitehead, A. et al "Once-daily tobramycin in the treatment of adult patients with cystic fibrosis." European Respiratory Journal 19.2 (2002): 303-309. Web. 16 Feb. 2020.

  13. Cornelissen, P.J.G.

    1. Vincken, W. et al "Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium." European Respiratory Journal 19.2 (2002): 209-216. Web. 16 Feb. 2020.

D

  1. Dab, I.

    1. App, E.M. et al "Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis." European Respiratory Journal 19.2 (2002): 294-302. Web. 16 Feb. 2020.

  2. Daures, J-P.

    1. Raherison, C. et al "Management of lower respiratory tract infections by French general practitioners: the AIR II study." European Respiratory Journal 19.2 (2002): 314-319. Web. 16 Feb. 2020.

  3. De Rose, V.

    1. De Rose, V.. "Mechanisms and markers of airway inflammation in cystic fibrosis." European Respiratory Journal 19.2 (2002): 333-340. Web. 16 Feb. 2020.

  4. Diaz-Jimenez, J.P.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  5. Dower, S.K.

    1. Sabroe, I. et al "Chemokines, innate and adaptive immunity, and respiratory disease." European Respiratory Journal 19.2 (2002): 350-355. Web. 16 Feb. 2020.

  6. Dumon, J.F.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

E

  1. Edell, E.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  2. Ennis, M.

    1. Warke, T.J. et al "Outgrown asthma does not mean no airways inflammation." European Respiratory Journal 19.2 (2002): 284-287. Web. 16 Feb. 2020.

  3. Etherington, C.

    1. Whitehead, A. et al "Once-daily tobramycin in the treatment of adult patients with cystic fibrosis." European Respiratory Journal 19.2 (2002): 303-309. Web. 16 Feb. 2020.

F

  1. Fernández de Sevilla, T.

    1. Alegre, J. et al "Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions." European Respiratory Journal 19.2 (2002): 320-325. Web. 16 Feb. 2020.

  2. Ferrer, A.

    1. Alegre, J. et al "Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions." European Respiratory Journal 19.2 (2002): 320-325. Web. 16 Feb. 2020.

  3. Fitch, P.S.

    1. Warke, T.J. et al "Outgrown asthma does not mean no airways inflammation." European Respiratory Journal 19.2 (2002): 284-287. Web. 16 Feb. 2020.

  4. Flaherty, K.R.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  5. Flint, A.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  6. Fok, T.F.

    1. Wong, G.W.K. et al "Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children." European Respiratory Journal 19.2 (2002): 288-293. Web. 16 Feb. 2020.

  7. Folgering, H.T.M.

    1. van Schayck, C.P. et al "Potential masking effect on dyspnoea perception by short- and long-acting β2-agonists in asthma." European Respiratory Journal 19.2 (2002): 240-245. Web. 16 Feb. 2020.

G

  1. Gaede, K.I.

    1. Gaede, K.I. et al "Anti-Chlamydophila immunoglobulin prevalence in sarcoidosis and usual interstitial pneumoniae." European Respiratory Journal 19.2 (2002): 267-274. Web. 16 Feb. 2020.

  2. Gelfand, E.W.

    1. Schwarze, J., and E.W. Gelfand. "Respiratory viral infections as promoters of allergic sensitization and asthma in animal models." European Respiratory Journal 19.2 (2002): 341-349. Web. 16 Feb. 2020.

  3. Giraud, V.

    1. Giraud, V., and N. Roche. "Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability." European Respiratory Journal 19.2 (2002): 246-251. Web. 16 Feb. 2020.

  4. Gjomarkaj, M.

    1. Melis, M. et al "Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects." European Respiratory Journal 19.2 (2002): 257-266. Web. 16 Feb. 2020.

  5. Gonzalez, J.

    1. Ioanas, M. et al "Bronchial bacterial colonization in patients with resectable lung carcinoma." European Respiratory Journal 19.2 (2002): 326-332. Web. 16 Feb. 2020.

  6. Gotoh, T.

    1. Iwasawa, T. et al "Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema." European Respiratory Journal 19.2 (2002): 225-231. Web. 16 Feb. 2020.

  7. Greefhorst, A.P.M.

    1. Vincken, W. et al "Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium." European Respiratory Journal 19.2 (2002): 209-216. Web. 16 Feb. 2020.

  8. Green, M.

    1. Hart, N. et al "A novel clinical test of respiratory muscle endurance." European Respiratory Journal 19.2 (2002): 232-239. Web. 16 Feb. 2020.

  9. Grignet, J-P.

    1. Raherison, C. et al "Management of lower respiratory tract infections by French general practitioners: the AIR II study." European Respiratory Journal 19.2 (2002): 314-319. Web. 16 Feb. 2020.

  10. Gross, B.H.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  11. Grosse, R.

    1. Spitzer, E. et al "Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient." European Respiratory Journal 19.2 (2002): 374-376. Web. 16 Feb. 2020.

H

  1. Hamnegård, C-H.

    1. Hart, N. et al "A novel clinical test of respiratory muscle endurance." European Respiratory Journal 19.2 (2002): 232-239. Web. 16 Feb. 2020.

  2. Hanke, R.

    1. Spitzer, E. et al "Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient." European Respiratory Journal 19.2 (2002): 374-376. Web. 16 Feb. 2020.

  3. Hart, N.

    1. Hart, N. et al "A novel clinical test of respiratory muscle endurance." European Respiratory Journal 19.2 (2002): 232-239. Web. 16 Feb. 2020.

  4. Hawkins, P.

    1. Hart, N. et al "A novel clinical test of respiratory muscle endurance." European Respiratory Journal 19.2 (2002): 232-239. Web. 16 Feb. 2020.

  5. Hodson, M.E.

    1. Madden, B.P. et al "Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure." European Respiratory Journal 19.2 (2002): 310-313. Web. 16 Feb. 2020.

  6. Hui, D.S.C.

    1. Wong, G.W.K. et al "Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children." European Respiratory Journal 19.2 (2002): 288-293. Web. 16 Feb. 2020.

I

  1. Ioanas, M.

    1. Ioanas, M. et al "Bronchial bacterial colonization in patients with resectable lung carcinoma." European Respiratory Journal 19.2 (2002): 326-332. Web. 16 Feb. 2020.

  2. Iwasawa, T.

    1. Iwasawa, T. et al "Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema." European Respiratory Journal 19.2 (2002): 225-231. Web. 16 Feb. 2020.

J

  1. Jain, A.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  2. Johns, D.P.

    1. Ward, R.J. et al "European Community Respiratory Health Survey calibration project of dosimeter driving pressures." European Respiratory Journal 19.2 (2002): 252-256. Web. 16 Feb. 2020.

  3. Jones, P.W.

    1. Casaburi, R. et al "A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease." European Respiratory Journal 19.2 (2002): 217-224. Web. 16 Feb. 2020.

  4. Jufresa, J.

    1. Alegre, J. et al "Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions." European Respiratory Journal 19.2 (2002): 320-325. Web. 16 Feb. 2020.

K

  1. Kagei, S.

    1. Iwasawa, T. et al "Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema." European Respiratory Journal 19.2 (2002): 225-231. Web. 16 Feb. 2020.

  2. Kariyawasam, H.

    1. Madden, B.P. et al "Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure." European Respiratory Journal 19.2 (2002): 310-313. Web. 16 Feb. 2020.

  3. Kazerooni, E.A.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  4. Kesten, S.

    1. Vincken, W. et al "Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium." European Respiratory Journal 19.2 (2002): 209-216. Web. 16 Feb. 2020.

  5. King, M.

    1. App, E.M. et al "Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis." European Respiratory Journal 19.2 (2002): 294-302. Web. 16 Feb. 2020.

  6. Korducki, L.

    1. Vincken, W. et al "Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium." European Respiratory Journal 19.2 (2002): 209-216. Web. 16 Feb. 2020.

  7. Kovitz, K.L.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  8. Kurihara, H.

    1. Iwasawa, T. et al "Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema." European Respiratory Journal 19.2 (2002): 225-231. Web. 16 Feb. 2020.

L

  1. Lai, C.K.W.

    1. Wong, G.W.K. et al "Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children." European Respiratory Journal 19.2 (2002): 288-293. Web. 16 Feb. 2020.

  2. Li, S.T.

    1. Wong, G.W.K. et al "Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children." European Respiratory Journal 19.2 (2002): 288-293. Web. 16 Feb. 2020.

  3. Lloyd, C.M.

    1. Sabroe, I. et al "Chemokines, innate and adaptive immunity, and respiratory disease." European Respiratory Journal 19.2 (2002): 350-355. Web. 16 Feb. 2020.

  4. Lynch, J.P.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  5. Lyons, J.D.M.

    1. Warke, T.J. et al "Outgrown asthma does not mean no airways inflammation." European Respiratory Journal 19.2 (2002): 284-287. Web. 16 Feb. 2020.

M

  1. Macha, H.N.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  2. Machin, A.

    1. Madden, B.P. et al "Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure." European Respiratory Journal 19.2 (2002): 310-313. Web. 16 Feb. 2020.

  3. Madden, B.P.

    1. Madden, B.P. et al "Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure." European Respiratory Journal 19.2 (2002): 310-313. Web. 16 Feb. 2020.

  4. Mahler, D.A.

    1. Casaburi, R. et al "A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease." European Respiratory Journal 19.2 (2002): 217-224. Web. 16 Feb. 2020.

  5. Malfroot, A.

    1. App, E.M. et al "Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis." European Respiratory Journal 19.2 (2002): 294-302. Web. 16 Feb. 2020.

  6. Marczynski, B.

    1. Merget, R. et al "Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate." European Respiratory Journal 19.2 (2002): 377-380. Web. 16 Feb. 2020.

  7. Marel, M.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  8. Marti, R.

    1. Alegre, J. et al "Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions." European Respiratory Journal 19.2 (2002): 320-325. Web. 16 Feb. 2020.

  9. Martinez, F.J.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  10. Matsubara, S.

    1. Iwasawa, T. et al "Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema." European Respiratory Journal 19.2 (2002): 225-231. Web. 16 Feb. 2020.

  11. Matsushita, K.

    1. Iwasawa, T. et al "Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema." European Respiratory Journal 19.2 (2002): 225-231. Web. 16 Feb. 2020.

  12. Mehta, A.C.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  13. Melis, M.

    1. Melis, M. et al "Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects." European Respiratory Journal 19.2 (2002): 257-266. Web. 16 Feb. 2020.

  14. Menjoge, S.S.

    1. Casaburi, R. et al "A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease." European Respiratory Journal 19.2 (2002): 217-224. Web. 16 Feb. 2020.

  15. Merget, R.

    1. Merget, R. et al "Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate." European Respiratory Journal 19.2 (2002): 377-380. Web. 16 Feb. 2020.

  16. Moxham, J.

    1. Hart, N. et al "A novel clinical test of respiratory muscle endurance." European Respiratory Journal 19.2 (2002): 232-239. Web. 16 Feb. 2020.

  17. Müller-Quernheim, J.

    1. Gaede, K.I. et al "Anti-Chlamydophila immunoglobulin prevalence in sarcoidosis and usual interstitial pneumoniae." European Respiratory Journal 19.2 (2002): 267-274. Web. 16 Feb. 2020.

N

  1. Noppen, M.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

P

  1. Pace, E.

    1. Melis, M. et al "Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects." European Respiratory Journal 19.2 (2002): 257-266. Web. 16 Feb. 2020.

  2. Paine, R.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  3. Pease, J.E.

    1. Sabroe, I. et al "Chemokines, innate and adaptive immunity, and respiratory disease." European Respiratory Journal 19.2 (2002): 350-355. Web. 16 Feb. 2020.

  4. Peray, P.

    1. Raherison, C. et al "Management of lower respiratory tract infections by French general practitioners: the AIR II study." European Respiratory Journal 19.2 (2002): 314-319. Web. 16 Feb. 2020.

  5. Pirazzoli, A.

    1. Melis, M. et al "Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects." European Respiratory Journal 19.2 (2002): 257-266. Web. 16 Feb. 2020.

  6. Poirier, R.

    1. Raherison, C. et al "Management of lower respiratory tract infections by French general practitioners: the AIR II study." European Respiratory Journal 19.2 (2002): 314-319. Web. 16 Feb. 2020.

  7. Polkey, M.I.

    1. Hart, N. et al "A novel clinical test of respiratory muscle endurance." European Respiratory Journal 19.2 (2002): 232-239. Web. 16 Feb. 2020.

  8. Profita, M.

    1. Melis, M. et al "Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects." European Respiratory Journal 19.2 (2002): 257-266. Web. 16 Feb. 2020.

  9. Pryor, J.A.

    1. Madden, B.P. et al "Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure." European Respiratory Journal 19.2 (2002): 310-313. Web. 16 Feb. 2020.

R

  1. Raherison, C.

    1. Raherison, C. et al "Management of lower respiratory tract infections by French general practitioners: the AIR II study." European Respiratory Journal 19.2 (2002): 314-319. Web. 16 Feb. 2020.

  2. Raulf-Heimsoth, M.

    1. Merget, R. et al "Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate." European Respiratory Journal 19.2 (2002): 377-380. Web. 16 Feb. 2020.

  3. Rees, P.J.

    1. Rees, P.J.. "Tiotropium in the management of chronic obstructive pulmonary disease." European Respiratory Journal 19.2 (2002): 205-206. Web. 16 Feb. 2020.

  4. Remberger, K.

    1. Merget, R. et al "Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate." European Respiratory Journal 19.2 (2002): 377-380. Web. 16 Feb. 2020.

  5. Roche, N.

    1. Giraud, V., and N. Roche. "Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability." European Respiratory Journal 19.2 (2002): 246-251. Web. 16 Feb. 2020.

  6. Romand, P.

    1. Raherison, C. et al "Management of lower respiratory tract infections by French general practitioners: the AIR II study." European Respiratory Journal 19.2 (2002): 314-319. Web. 16 Feb. 2020.

  7. Ruiz, E.

    1. Alegre, J. et al "Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions." European Respiratory Journal 19.2 (2002): 320-325. Web. 16 Feb. 2020.

S

  1. Sabroe, I.

    1. Sabroe, I. et al "Chemokines, innate and adaptive immunity, and respiratory disease." European Respiratory Journal 19.2 (2002): 350-355. Web. 16 Feb. 2020.

  2. Saito, K.

    1. Iwasawa, T. et al "Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema." European Respiratory Journal 19.2 (2002): 225-231. Web. 16 Feb. 2020.

  3. San Pedro, G.

    1. Casaburi, R. et al "A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease." European Respiratory Journal 19.2 (2002): 217-224. Web. 16 Feb. 2020.

  4. Schlaak, M.

    1. Gaede, K.I. et al "Anti-Chlamydophila immunoglobulin prevalence in sarcoidosis and usual interstitial pneumoniae." European Respiratory Journal 19.2 (2002): 267-274. Web. 16 Feb. 2020.

  5. Schwarze, J.

    1. Schwarze, J., and E.W. Gelfand. "Respiratory viral infections as promoters of allergic sensitization and asthma in animal models." European Respiratory Journal 19.2 (2002): 341-349. Web. 16 Feb. 2020.

  6. Segura, R.

    1. Alegre, J. et al "Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions." European Respiratory Journal 19.2 (2002): 320-325. Web. 16 Feb. 2020.

  7. Serby, C.W.

    1. Casaburi, R. et al "A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease." European Respiratory Journal 19.2 (2002): 217-224. Web. 16 Feb. 2020.

  8. Setchfield, N.

    1. Whitehead, A. et al "Once-daily tobramycin in the treatment of adult patients with cystic fibrosis." European Respiratory Journal 19.2 (2002): 303-309. Web. 16 Feb. 2020.

  9. Shields, M.D.

    1. Warke, T.J. et al "Outgrown asthma does not mean no airways inflammation." European Respiratory Journal 19.2 (2002): 284-287. Web. 16 Feb. 2020.

  10. Shusterman, D.

    1. Shusterman, D. et al "Chlorine exposure and the upper respiratory tract." European Respiratory Journal 19.2 (2002): 381-383. Web. 16 Feb. 2020.

  11. Siddiqi, A.J.

    1. Madden, B.P. et al "Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure." European Respiratory Journal 19.2 (2002): 310-313. Web. 16 Feb. 2020.

  12. Siena, L.

    1. Melis, M. et al "Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects." European Respiratory Journal 19.2 (2002): 257-266. Web. 16 Feb. 2020.

  13. Skoric, B.

    1. Ward, R.J. et al "European Community Respiratory Health Survey calibration project of dosimeter driving pressures." European Respiratory Journal 19.2 (2002): 252-256. Web. 16 Feb. 2020.

  14. Solomon, C.

    1. Shusterman, D. et al "Chlorine exposure and the upper respiratory tract." European Respiratory Journal 19.2 (2002): 381-383. Web. 16 Feb. 2020.

  15. Spitzer, E.

    1. Spitzer, E. et al "Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient." European Respiratory Journal 19.2 (2002): 374-376. Web. 16 Feb. 2020.

  16. Staab, D.

    1. Spitzer, E. et al "Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient." European Respiratory Journal 19.2 (2002): 374-376. Web. 16 Feb. 2020.

  17. Stassi, G.

    1. Melis, M. et al "Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects." European Respiratory Journal 19.2 (2002): 257-266. Web. 16 Feb. 2020.

  18. Strausz, J.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

  19. Strawderman, R.L.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  20. Sutedja, T.G.

    1. Beamis, J.F. et al "ERS/ATS statement on interventional pulmonology." European Respiratory Journal 19.2 (2002): 356-373. Web. 16 Feb. 2020.

T

  1. Taylor, R.

    1. Warke, T.J. et al "Outgrown asthma does not mean no airways inflammation." European Respiratory Journal 19.2 (2002): 284-287. Web. 16 Feb. 2020.

  2. Taytard, A.

    1. Raherison, C. et al "Management of lower respiratory tract infections by French general practitioners: the AIR II study." European Respiratory Journal 19.2 (2002): 314-319. Web. 16 Feb. 2020.

  3. Todaro, M.

    1. Melis, M. et al "Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects." European Respiratory Journal 19.2 (2002): 257-266. Web. 16 Feb. 2020.

  4. Toews, G.B.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

  5. Torres, A.

    1. Ioanas, M. et al "Bronchial bacterial colonization in patients with resectable lung carcinoma." European Respiratory Journal 19.2 (2002): 326-332. Web. 16 Feb. 2020.

  6. Travis, W.D.

    1. Flaherty, K.R. et al "Clinical significance of histological classification of idiopathic interstitial pneumonia." European Respiratory Journal 19.2 (2002): 275-283. Web. 16 Feb. 2020.

V

  1. Vanderbist, F.

    1. App, E.M. et al "Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis." European Respiratory Journal 19.2 (2002): 294-302. Web. 16 Feb. 2020.

  2. van der Elshout, F.J.J.

    1. van Schayck, C.P. et al "Potential masking effect on dyspnoea perception by short- and long-acting β2-agonists in asthma." European Respiratory Journal 19.2 (2002): 240-245. Web. 16 Feb. 2020.

  3. van Noord, J.A.

    1. Vincken, W. et al "Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium." European Respiratory Journal 19.2 (2002): 209-216. Web. 16 Feb. 2020.

  4. van Schayck, C.P.

    1. van Schayck, C.P. et al "Potential masking effect on dyspnoea perception by short- and long-acting β2-agonists in asthma." European Respiratory Journal 19.2 (2002): 240-245. Web. 16 Feb. 2020.

  5. Van Weel, C.

    1. van Schayck, C.P. et al "Potential masking effect on dyspnoea perception by short- and long-acting β2-agonists in asthma." European Respiratory Journal 19.2 (2002): 240-245. Web. 16 Feb. 2020.

  6. Vignola, A.M.

    1. Melis, M. et al "Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects." European Respiratory Journal 19.2 (2002): 257-266. Web. 16 Feb. 2020.

  7. Vincken, W.

    1. Vincken, W. et al "Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium." European Respiratory Journal 19.2 (2002): 209-216. Web. 16 Feb. 2020.

W

  1. Wahn, U.

    1. Spitzer, E. et al "Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient." European Respiratory Journal 19.2 (2002): 374-376. Web. 16 Feb. 2020.

  2. Walters, E.H.

    1. Ward, R.J. et al "European Community Respiratory Health Survey calibration project of dosimeter driving pressures." European Respiratory Journal 19.2 (2002): 252-256. Web. 16 Feb. 2020.

  3. Wanner, A.

    1. Casaburi, R. et al "A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease." European Respiratory Journal 19.2 (2002): 217-224. Web. 16 Feb. 2020.

  4. Ward, C.

    1. Ward, R.J. et al "European Community Respiratory Health Survey calibration project of dosimeter driving pressures." European Respiratory Journal 19.2 (2002): 252-256. Web. 16 Feb. 2020.

  5. Ward, R.J.

    1. Ward, R.J. et al "European Community Respiratory Health Survey calibration project of dosimeter driving pressures." European Respiratory Journal 19.2 (2002): 252-256. Web. 16 Feb. 2020.

  6. Warke, T.J.

    1. Warke, T.J. et al "Outgrown asthma does not mean no airways inflammation." European Respiratory Journal 19.2 (2002): 284-287. Web. 16 Feb. 2020.

  7. Whitehead, A.

    1. Whitehead, A. et al "Once-daily tobramycin in the treatment of adult patients with cystic fibrosis." European Respiratory Journal 19.2 (2002): 303-309. Web. 16 Feb. 2020.

  8. Whyte, M.K.B.

    1. Sabroe, I. et al "Chemokines, innate and adaptive immunity, and respiratory disease." European Respiratory Journal 19.2 (2002): 350-355. Web. 16 Feb. 2020.

  9. Wilke, G.

    1. Gaede, K.I. et al "Anti-Chlamydophila immunoglobulin prevalence in sarcoidosis and usual interstitial pneumoniae." European Respiratory Journal 19.2 (2002): 267-274. Web. 16 Feb. 2020.

  10. Williams, T.J.

    1. Sabroe, I. et al "Chemokines, innate and adaptive immunity, and respiratory disease." European Respiratory Journal 19.2 (2002): 350-355. Web. 16 Feb. 2020.

  11. Willroth, P.O.

    1. Merget, R. et al "Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate." European Respiratory Journal 19.2 (2002): 377-380. Web. 16 Feb. 2020.

  12. Witek, T.

    1. Casaburi, R. et al "A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease." European Respiratory Journal 19.2 (2002): 217-224. Web. 16 Feb. 2020.

  13. Wong, G.W.K.

    1. Wong, G.W.K. et al "Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children." European Respiratory Journal 19.2 (2002): 288-293. Web. 16 Feb. 2020.

Y

  1. Yoshiike, Y.

    1. Iwasawa, T. et al "Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema." European Respiratory Journal 19.2 (2002): 225-231. Web. 16 Feb. 2020.

Z

  1. Zhong, N.S.

    1. Wong, G.W.K. et al "Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children." European Respiratory Journal 19.2 (2002): 288-293. Web. 16 Feb. 2020.

  2. ZuWallack, R.L.

    1. Casaburi, R. et al "A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease." European Respiratory Journal 19.2 (2002): 217-224. Web. 16 Feb. 2020.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts